(Q35636520)

9 August 2017

title

Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings (English)

1 reference

9 August 2017

0 references

Robert L Murphy

14

0 references

Phyllis J Kanki

15

object named as

Phyllis J Kanki

1 reference

9 August 2017

Holly E Rawizza

1

1 reference

9 August 2017

Beth Chaplin

2

1 reference

9 August 2017

Seema T Meloni

3

1 reference

9 August 2017

Geoffrey Eisen

4

1 reference

9 August 2017

Tara Rao

5

1 reference

9 August 2017

Jean-Louis Sankalé

6

1 reference

9 August 2017

Abdoulaye Dieng-Sarr

7

1 reference

9 August 2017

Oche Agbaji

8

1 reference

9 August 2017

Daniel I Onwujekwe

9

1 reference

9 August 2017

Wadzani Gashau

10

1 reference

9 August 2017

Reuben Nkado

11

1 reference

9 August 2017

Ernest Ekong

12

1 reference

9 August 2017

Prosper Okonkwo

13

1 reference

9 August 2017

APIN PEPFAR Team

16

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

Clinical Infectious Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

53

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

1283-1290

1 reference

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Laboratory medicine in Africa: a barrier to effective health care

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

HIV viral load monitoring in resource-limited regions: optional or necessary?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

A survival method to estimate the time to occurrence of mutations: an application to thymidine analogue mutations in HIV-1-infected patients

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246873

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIR729

Performance of Immunologic Responses in Predicting Viral Load Suppression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIR729

Adherence is not a barrier to successful antiretroviral therapy in South Africa

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIR729

21 January 2018

12 December 2020

DART points the way for HIV treatment programmes

1 reference

12 December 2020

Drug resistance after failure of initial antiretroviral therapy in resource-limited countries

1 reference

12 December 2020

Running with scissors: using antiretroviral therapy without monitoring viral load

1 reference

12 December 2020

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIR729

1 reference

9 August 2017

1 reference

9 August 2017

1 reference